NRG GI008 CIRCULATE-US

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease PROTOCOL CONSENT HIPAA-CON HIPAA-MANCH

Objective

This Phase II/III trial will evaluate the kind of chemotherapy to recommend to patients based on the presence or absence of circulating tumor DNA (ctDNA) after surgery for colon cancer.

NCT#05174169

Clinical Trial Categories

• Colorectal Cancer

Contact

NH Oncology Hematology Clinical Research Dept. at (603) 224-2556